Avid Bioservices to Participate in RBC Capital Markets Global Healthcare Conference

Avid Bioservices Unveils Completed Mammalian Cell Facilities Expansion Providing Significantly Increased Capacity for Existing and Future Customers

Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2023, and Recent Developments

Avid Bioservices to Report Financial Results for Third Quarter of Fiscal Year 2023 After Market Close on March 13, 2023

Avid Bioservices Reports Financial Results for Second Quarter Ended October 31, 2022 and Recent Developments

Avid Bioservices to Report Financial Results for Second Quarter of Fiscal Year 2023 After Market Close on December 6, 2022

Avid Bioservices Appoints Oksana Lukash as Vice President, People

Avid Bioservices to Participate in the Credit Suisse 31st Annual Healthcare Conference

Avid Bioservices to Participate in RBC Global CDMO Conference

Avid Bioservices Appoints Michael Alston, Jr. as Vice President, Operations